A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon

Am J Kidney Dis. 2022 Nov;80(5):677-682. doi: 10.1053/j.ajkd.2022.05.008. Epub 2022 Jul 9.

Abstract

Adenosine deaminase 2 (ADA2) deficiency is a rare autosomal recessive disease that is caused by loss-of-function mutations in the ADA2 gene. It is considered a monogenic form of polyarteritis nodosa and frequently is positive for a type I interferon (IFN) signature. Renal manifestations in ADA2 deficiency are poorly characterized. We herein report 2 cases of ADA2 deficiency with different kidney patterns due, respectively, to a predominantly macroscopic and microscopic vasculopathy, and review the literature on kidney disease in ADA2 deficiency. Patient 1 presented with a spontaneous perirenal hematoma; angiography demonstrated multiple microaneurysms but no further defects of the renal parenchyma; his kidney function remained normal. Patient 2 experienced slowly deteriorating kidney function and proteinuria. No major angiographic abnormalities were detected, while kidney biopsy revealed massive vasculopathy resembling chronic thrombotic microangiopathy (TMA) of the small and medium-sized vessels. Both patients had a positive peripheral type I IFN signature. In immunofluorescence staining of a kidney biopsy sample from patient 2, we observed marked expression of the type I IFN-induced protein MXA within endothelial cells, especially in vessels with TMA, and in infiltrating T cells. Our findings confirm that the kidney phenotype of ADA2 deficiency results from small and medium-sized vessel vasculopathy and suggest that type I IFN may be involved in the pathogenesis of kidney lesions.

Keywords: ADA deficiency; Adenosine deaminase 2 (ADA2); Aneurysm; Case report; Genetic variant; Glomerulonephritis; Kidney biopsy; Polyarteritis nodosa (PAN); Renal vasculopathy; Type I IFN response; Type I interferon (IFN-I); Vasculitis.

Publication types

  • Case Reports

MeSH terms

  • Adenosine Deaminase / genetics
  • Endothelial Cells
  • Humans
  • Intercellular Signaling Peptides and Proteins / genetics
  • Interferon Type I*
  • Kidney
  • Mutation
  • Phenotype
  • Polyarteritis Nodosa* / genetics
  • Vascular Diseases*

Substances

  • Adenosine Deaminase
  • Interferon Type I
  • Intercellular Signaling Peptides and Proteins

Supplementary concepts

  • Severe combined immunodeficiency due to adenosine deaminase deficiency